MedPath
HSA Approval

COUGH RELIEF SYRUP 100 mg/5 ml

SIN08969P

COUGH RELIEF SYRUP 100 mg/5 ml

COUGH RELIEF SYRUP 100 mg/5 ml

October 21, 1996

WEN KEN MARKETING (S) PTE LTD

WEN KEN MARKETING (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantWEN KEN MARKETING (S) PTE LTD
Licence HolderWEN KEN MARKETING (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05CA03

guaifenesin

Manufacturer Information

WEN KEN MARKETING (S) PTE LTD

SYARIKAT WEN KEN DRUG SDN BHD

Active Ingredients

GUAIPHENESIN

100 mg/ 5 ml

Guaifenesin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COUGH RELIEF SYRUP 100 mg/5 ml - HSA Approval | MedPath